Phase II study of combination cisplatin, docetaxel and erlotinib in patients with metastatic/recurrent head and neck squamous cell carcinoma (HNSCC)
暂无分享,去创建一个
Edward S. Kim | S. Lippman | W. Hong | A. Tsao | M. Truong | L. Ginsberg | M. Kies | B. Glisson | B. Burke | F. Holsinger